Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion type Assertion NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_head.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion description "[Polymorphic variations in the MTR, SLC19A1, and TYMS genes were associated with better clinical response to combination DMARD regimens containing MTX and SSZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_provenance.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion evidence source_evidence_literature NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_provenance.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion SIO_000772 18322994 NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_provenance.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion wasDerivedFrom gad-20150221 NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_provenance.
- NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_assertion wasGeneratedBy ECO_0000203 NP119876.RA7uAgAYMwXjL5EK7xlZ4HXN_qeFWo9BQoCWUy1FCNDr0130_provenance.